Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "retinal microenvironment and neural circuitry" encompasses the complex network of neurons (photoreceptors, bipolar cells, horizontal cells, amacrine cells, ganglion cells), glial cells (such as Müller glia and astrocytes), the retinal pigment epithelium, vascular elements, and the extracellular matrix within the retina[1][6][3][4]. These elements work together to process and transmit visual information from photoreceptors through intermediate cells to ganglion cells, which project to the brain via the optic nerve. The microenvironment also includes homeostatic mechanisms, glial support functions, metabolic coupling, and immune cells like microglia[3][4]. The circuitry involves parallel excitatory and inhibitory pathways, intricate lateral and feedback connections, and is critical for visual processing, plasticity, and adaptation. Disruption to any aspect of this environment or its circuitry can contribute to a variety of retinal and neurodegenerative diseases, but the term itself does not denote a specific molecular therapeutic target[1][6][3][4][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Retinal microenvironment and neural circuitry.